Hyperelodiones A-C, monoterpenoid polyprenylated acylphoroglucinols from Hypericum elodeoides, induce cancer cells apoptosis by targeting RXRα
Hyperelodiones A-C, monoterpenoid polyprenylated acylphoroglucinols from Hypericum elodeoides, induce cancer cells apoptosis by targeting RXRα
复制标题
DOI:
10.1016/j.phytochem.2019.112216
复制
发表时间:
2020-02-01
期刊:
影响因子:
3.8
通讯作者:
Chen, Haifeng
中科院分区:
文献类型:
--
作者:
Qiu, Daren;Zhou, Mi;Chen, Haifeng
Hyperelodiones A-C, three undescribed monoterpenoid polyprenylated acylphloroglucinols possessing 6/6/6 fused tricyclic core, were isolated from Hypericum elodeoides Choisy. Their gross structures were elucidated by HRESIMS and NMR data. The absolute configurations of hyperelodiones A-C were assigned by their calculated and compared electronic circular dichroism (ECD) spectra combined with their common biosynthetic origin. A fluorescence quenching assay suggested that hyperelodiones A-C could bind to RXR alpha-LBD, whereas hyperelodione C showed the strongest interaction with a K-D of 12.81 mu M. In addition, hyperelodiones A-C dose-dependently inhibited RXR alpha transactivation and the growth of HeLa and MCF-7 cells. Among them, hyperelodione C showed the most potent inhibitory activities and dose-dependent PARP cleavage. Molecular docking results suggested that hyperelodione C showed a different interaction mode compared with hyperelodione A and hyperelodione B. Thus, hyperelodione C can be considered as a promising lead compound for cancer therapy, which can bind to RXR alpha-LBD and induce HeLa and MCF-7 cell apoptosis.